Europe — EMA

Oxaliplatino Accord

Oxaliplatin, the active ingredient in Oxaliplatino Accord, is a platinum‑based chemotherapy agent presented as a sterile powder for intravenous infusion use.

Oxaliplatin

Request sourcing

Pack/s

What is Oxaliplatin?

Oxaliplatin, the active ingredient in Oxaliplatino Accord, is a platinum‑based chemotherapy agent presented as a sterile powder for intravenous infusion use. It treats colorectal cancer and is administered under the supervision of oncology specialists.

GNH USA supplies Oxaliplatino Accord as a licensed, GDP‑compliant international pharmaceutical supplier serving oncology centres, hospitals and pharmacies worldwide.

What is Oxaliplatin used for?

Oxaliplatin is used in colorectal cancer treatment protocols, targeting the disease progression within the gastrointestinal tract. - Metastatic colorectal cancer: Improves overall survival and progression‑free progressi on by adding to flu‑ F‑ F . - Adjuvant t : - Neoadjucomb "); - - -

What are the side effects of Oxaliplatin?

Oxaliplatin

Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.

Send a sourcing enquiry for this product →